<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03453580</url>
  </required_header>
  <id_info>
    <org_study_id>MSCT GRADING</org_study_id>
    <nct_id>NCT03453580</nct_id>
  </id_info>
  <brief_title>CT Portography in Grading of Liver Cirrhosis</brief_title>
  <official_title>Role of Multi Slice Computed Tomography Portography in Grading of Liver Cirrhosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Esophageal variceal bleeding and hepatic encephalopathy are serious complications of hepatic
      cirrhosis, and they may lead to high mortality rate and severely threaten life quality of the
      patients
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The occurrence and development of Esophageal variceal bleeding and hepatic encephalopathy are
      closely related with portal vein system diseases, such as collateral circulation of portal
      hypertension and portal vein thrombosis.

      The prevention of Esophageal variceal bleeding and hepatic encephalopathy in hepatic
      cirrhosis has become a hot spot in clinical practice.

      Three-dimensional reconstruction of images obtained by multi-slice spiral computed tomography
      portography (MSCTP) is clear, realistic, and accurate.

      It can directly and quickly display all anatomical information of collateral portal vein
      system, and is recognized as a good method to display blood vessels
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 25, 2018</start_date>
  <completion_date type="Anticipated">October 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Grading of liver cirrhosis</measure>
    <time_frame>15 min</time_frame>
    <description>Grade I: i)level 4-5 by portal development will achieved in intrahepatic portal vein imaging; ii) collateral circulation mainly open at esophageal gastric fundus vein, or one branch of para-umbilical vein or esophageal peripheral vein was open; iii) hepatic artery-portal vein fistula or portal vein embolus was not formed.
Grade II: i)level 3-4 by portal development will achieved in intrahepatic portal vein imaging; ii) in addition to opening of collateral circulation at esophageal gastric fundus vein, 2-3 branches of para-umbilical vein or esophageal peripheral vein open; iii) some hepatic artery-portal vein fistula or portal vein embolus not observed.
Grade lll: level 2-3 by portal development are achieved in intrahepatic portal vein imaging; ii) esophageal gastric fundus vein, para-umbilical vein or esophageal peripheral vein all open, iii) hepatic artery-portal vein fistula or portal vein embolus is formed.
Then we will do correlation with child -pugh score</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>prediction of esophageal varices and hepatic encephalopathy</measure>
    <time_frame>20 min</time_frame>
    <description>measuring diameters of main portal vein,left gastric, splenic, intra hepatic right and left portal vein.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">68</enrollment>
  <condition>CT Portography Grading of Liver Cirrhosis</condition>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>multislice computed tomography portography</intervention_name>
    <description>imaging modality</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        liver cirrhosis
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with cirrhosis and\or portal hypertension diagnosed by; laboratory or
             radiological parameters.

        Exclusion Criteria:

          -  Patients with ligation, disconnection or shunting of esophageal varices. Patients with
             combined hepatic malignant tumor Patients with splenectomy. Patients with renal
             dysfunction or iodine allergy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Mostafa Hashem Mahmoud, professor</last_name>
    <phone>01000684012</phone>
    <email>hashemradiol@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marwa Mohamed Samy Mohamed, lecturer</last_name>
    <phone>01025260404</phone>
    <email>marwasamy2014@gmail.com</email>
  </overall_contact_backup>
  <results_reference>
    <citation>Biecker E. Gastrointestinal Bleeding in Cirrhotic Patients with Portal Hypertension. ISRN Hepatol. 2013 Jul 22;2013:541836. doi: 10.1155/2013/541836. eCollection 2013. Review.</citation>
    <PMID>27335828</PMID>
  </results_reference>
  <results_reference>
    <citation>Bajaj JS. Review article: potential mechanisms of action of rifaximin in the management of hepatic encephalopathy and other complications of cirrhosis. Aliment Pharmacol Ther. 2016 Jan;43 Suppl 1:11-26. doi: 10.1111/apt.13435. Review.</citation>
    <PMID>26618922</PMID>
  </results_reference>
  <results_reference>
    <citation>Chu Q, Li Z, Zhang SM, Hu DY, Xiao M. Relationship between encephalopathy and portal vein-vena cava shunt: value of computed tomography during arterial portography. World J Gastroenterol. 2004 Jul 1;10(13):1939-42.</citation>
    <PMID>15222041</PMID>
  </results_reference>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 27, 2018</study_first_submitted>
  <study_first_submitted_qc>February 27, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 5, 2018</study_first_posted>
  <last_update_submitted>February 27, 2018</last_update_submitted>
  <last_update_submitted_qc>February 27, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 5, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Doaa Hamza</investigator_full_name>
    <investigator_title>principal investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Liver Cirrhosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

